Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(9 sites)
United States
Hoag Memorial Hospital Presbyterian, Newport Beach, California Washington University, St Louis, Missouri Astera Cancer Care, East Brunswick, New Jersey Memorial Sloan Kettering Cancer Center, New York, New York MD Anderson Cancer Center, Houston, Texas Oncology Consultants, Houston, Texas Mays Cancer Center; University of Texas Health San Antonio, San Antonio, Texas University of Washington / Fred Hutchinson Cancer Center, Seattle, Washington Northwest Medical Specialties, PLLC, Tacoma, Washington